Search

everythinglearnresearchcommunity

for

Search:↓

Genetic factors alone might not cause pemphigus vulgaris; other factors like birth complications and puberty may trigger it.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

FDG PET/CT scans can change cancer treatment plans for dogs.

Minoxidil helps prevent hair loss from chemotherapy in rats.

Bimatoprost is safe and improves eyelash growth in healthy kids but not in those with eyelash loss from chemotherapy or alopecia.

Polygonum multiflorum extract helps hair grow longer and fights the effects of hormones that cause hair loss.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Stem cells compete for space using cell adhesion, and mutations can affect their competitive success, with implications for tissue health and disease.

The document suggests a need for collaboration, better evidence, and a responsible framework to safely and effectively advance regenerative therapies to clinical use.

Various hair camouflage options help people with hair loss improve appearance.

Oncogenic K-ras causes rapid cancerous changes in the mouth's lining.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

The conclusion is that there is a high demand for new contraceptives that provide both pregnancy prevention and protection against STIs, along with additional health benefits.

Low iron levels are a significant risk factor for hair loss, while high vitamin D levels might be a response to hair loss, not a cause.

Taking Propecia might lead to the development of cataracts.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

A woman's scalp nodules were successfully treated with antifungal and anti-lice medications, revealing a rare case of mixed piedra infection.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

Temporary hair loss can occur after brain AVM treatment but usually regrows in 8 weeks.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Stem cell therapies show promise for treating various diseases but face challenges in clinical use and require better monitoring techniques.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Men with liver cancer have higher levels of a specific testosterone byproduct in their liver and blood, despite overall lower male hormone levels.